• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
Renee Rodgers on what it means to be a woman in science
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Discovery

Women in Science: Renee Rodgers

May 15, 2017

Executive Director and Head of Digital Strategy for US Oncology at Novartis, Renee Rodgers
Renee Rodgers, Executive Director and Head of Digital Strategy, US Oncology, Novartis

We’re excited and proud to announce that our very own Renee Rodgers, who serves as Executive Director and Head of Digital Strategy for US Oncology at Novartis, has made MM&M magazine’s 2017 Top 40 Healthcare Transformers list. MM&M (Medical Marketing and Media) is a US outlet that annually recognizes 40 innovators who are transforming the biopharmaceuticals industry.

Rodgers and her team are constantly pushing the envelope when it comes to technology, using exciting new methods such as artificial intelligence to improve the digital experience for patients and healthcare providers. Hear more from Rodgers in this installment of “Novartis Presents: Women in Science.”

What does it mean to you to be recognized as an innovator in this industry?

Being recognized as an innovator in an industry focused on improving patients’ lives is a great honor. Our role at the intersection of healthcare and technology is becoming more important, and this recognition highlights our work.

You were recognized because of your focus on innovation and your work in artificial intelligence and other forms of technology to improve the digital experience for both patients and healthcare providers. Can you speak a little bit about that and what you and your team are doing as leaders in this field?

Data has become the new shiny object for innovation. However, for us, data is the “what” – and it’s “how” we use data with technology that is important. Our patient and customer expectations are raised continuously by technology leaders. We live in a world where almost anything is available on demand, and as a result, those same consumers wonder why it can be hard to interact with us. Data helps us give patients the support they need at the moments that may matter along their journey.

Ultimately we are working on harnessing the power of data to help make access to healthcare much simpler for patients.

How do you plan to improve the patient‘s journey through digital experience and innovation?

So much of what we do is business transformation, bringing together multiple functions to solve business issues that may positively impact these individuals. If a patient must verify their information every year for copay assistance, let’s make it simple. If transportation is an issue for patients, how can we help?

How do you see technology continuing to shape the world of oncology?

Speed. With technology, we can process more data, which can help us see a patient’s journey more accurately, and rapidly identify bottlenecks in a very complex healthcare system.

What excites you about the future of healthcare and technology, and how do you plan on continuing to innovate in this field moving forward?

Ultimately we are working on harnessing the power of data to help make access to healthcare much simpler for patients.

women-in-science-tania-small
Discovery

Women in Science: Tania Small

What advice would you give to those looking to establish themselves in the world of technology and healthcare?

Focus on the patients’ needs, bring your innovative ideas, and be prepared to collaborate. 


“Novartis Presents: Women in Science” is an ongoing series showcasing women at Novartis who are helping develop innovative oncology medicines for people with cancer and related diseases. 

Shareline

Meet Renee Rodgers of Novartis, named a top 40 #healthcare transformer by MM&M magazine. #WomenInScience
Tweet Tweetpopo
Tags: 
Digital, Emerging Technology, Innovation, Oncology, Women in Science, Working at Novartis
Disclaimer: 

Responses have been edited for length.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

RNA strand
Discovery

Take a visual tour of medicines that target RNA

A kidney patient is smiling at the camera
Discovery

New hope for treating inflammatory diseases of the kidney

2D rendering of kidneys
Discovery

Predictive analytics could bring medicines to patients faster

You are here

  1. Home ›
  2. Stories ›
  3. Discovery

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.